II. Epidemiology
- Most common cause of severe Visual Impairment in U.S.
- Present in 70% of patients older than 70 years old
III. Pathophysiology
- Opacification of the crystalline lens of the eye
- Stages of development- Immature Cataract- Opacities separated by areas of clear lens
 
- Mature Cataract- Complete lens opacification
 
- Hypermature Cataract- Lens cortex is liquefied
- Lens capsule looses fluid- Risk of Inflammatory reaction
- Risk of secondary Glaucoma
 
 
 
- Immature Cataract
IV. Locations
- Nuclear Cataracts- Central lens (nucleus) becomes dense and sclerotic
- Discolored by yellow, brown or gray hue
 
- Cortical Cataracts- Peripheral opacities
- Radiating spokes appearance on Slit Lamp exam
 
- Posterior Subcapsular Cataracts- Most rapidly progressive
- Seen in younger patients and those on Corticosteroid
 
V. Risk factors
- Normal Aging (90% of cases)
- Tobacco Abuse
- Ocular UV-B light exposure
- Traumatic Injury to lens or capsule
- Comorbid conditions
- Medication related- Systemic Corticosteroid
- Topical EchothiophateIodide (Glaucoma treatment)
 
VI. Symptoms
- Progressive reduced Vision (usually bilateral)- Patients report Clouding or fogging of Vision
- Nuclear Cataracts may improve site temporarily- Cataract sclerosis changes shape of Lens nucleus
- Myopia may result and may correct Farsightedness
 
 
- Skewed Color Perception- Lens becomes pigmented in nuclear sclerotic Cataracts
- Blues filtered out
- Color is shifted to yellow and red part of spectrum
 
- Diminished Vision in bright light- Central opacities block light when pupil constricts
- Glare may also occur
- Reduced night Vision (with halos in Visual Fields)
 
VII. Signs
- Lenticular opacities of various shapes and degree
- Technique- Set ophthalmoscope to +10
- View lens from 12 inches from patient's face
- Cataracts appear as dark areas against red pupil
- Red Reflex overall appears dull
 
- Consider dilating pupil for exam- Phenylephrine hydrochloride Ophthalmic Solution- Not Cycloplegic
- Does not affect close Vision
 
 
- Phenylephrine hydrochloride Ophthalmic Solution
VIII. Management
- Assessment of concurrent eye disorder- Glaucoma
- Retinal Detachment
- Macular Degeneration
- Retinal vascular occlusive disease
- Retinopathy of Diabetes
- Hypertension
- Arteriosclerosis
 
- Maximize Refractive Error correction with glasses
- Consider dilating drops to improve Vision
- Ophthalmology referral for Cataract Extraction- Procedure- Phacoemulsification with intraocular lens replacement
 
- Indications (Refer for impaired function or refractory symptoms)
- References
 
- Procedure
IX. Prevention
- Avoid excessive UV Light exposure
- Smoking Cessation
